内溶性干扰素α-2b作为一种新的治疗方法,用于马的周期性状细胞癌

Brittany B Martabano1, Steven Dow1, Lyndah Chow1

  • 1Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.

PloS one
|February 21, 2024
PubMed
概括

临性干扰素α-2b (IFNα2b) 注射有效地治疗马的周期性状细胞癌 (PSCC). 这种马类癌症治疗耐受性良好,没有观察到系统性副作用,治疗眼睛的42%的瘤回归.